Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The clinical impact of the Covid-19 pandemic first wave on patients with cystic fibrosis in New York.
Simonson JL, Esposito C, Frantzen T, Henthorne K, Espinal A, Romano S, Ramdeo R, Trentacoste J, Tsang D, LaVecchia G, Abdullah R, Berdella M, Bonitz L, Condos R, Constantinescu A, DeCelie-Germana JK, DiMango E, Draine M, Gimeli T, Giusti R, Guzman J, Hammouda S, Keating C, Kier C, Lennox AT, Liriano C, Messer Z, Plachta A, Sadeghi H, Schwind E, Stables-Carney T, Walker P, Wang J. Simonson JL, et al. Among authors: lennox at. J Cyst Fibros. 2022 May;21(3):e176-e183. doi: 10.1016/j.jcf.2022.02.012. Epub 2022 Feb 21. J Cyst Fibros. 2022. PMID: 35256307 Free PMC article.
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials.
Mayer-Hamblett N, Ratjen F, Russell R, Donaldson SH, Riekert KA, Sawicki GS, Odem-Davis K, Young JK, Rosenbluth D, Taylor-Cousar JL, Goss CH, Retsch-Bogart G, Clancy JP, Genatossio A, O'Sullivan BP, Berlinski A, Millard SL, Omlor G, Wyatt CA, Moffett K, Nichols DP, Gifford AH; SIMPLIFY Study Group. Mayer-Hamblett N, et al. Lancet Respir Med. 2023 Apr;11(4):329-340. doi: 10.1016/S2213-2600(22)00434-9. Epub 2022 Nov 4. Lancet Respir Med. 2023. PMID: 36343646 Free PMC article. Clinical Trial.
Multiprobe Nuclear Imaging of the Cystic Fibrosis Lung as a Biomarker of Therapeutic Effect.
Corcoran TE, Huber AS, Myerburg MM, Weiner DJ, Locke LW, Lacy RT, Weber L, Czachowski MR, Johnston DJ, Muthukrishnan A, Lennox AT, Pilewski JM. Corcoran TE, et al. Among authors: lennox at. J Aerosol Med Pulm Drug Deliv. 2019 Aug;32(4):242-249. doi: 10.1089/jamp.2018.1491. Epub 2019 Apr 10. J Aerosol Med Pulm Drug Deliv. 2019. PMID: 30969149 Free PMC article.
SPX-101 Is a Promising and Novel Nebulized ENaC Inhibitor.
Lennox A, Myerburg MM. Lennox A, et al. Am J Respir Crit Care Med. 2017 Sep 15;196(6):671-672. doi: 10.1164/rccm.201705-0928ED. Am J Respir Crit Care Med. 2017. PMID: 28609635 Free PMC article. No abstract available.